Insider Transactions in Q3 2024 at Neurocrine Biosciences Inc (NBIX)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 13
2024
|
David W. Boyer Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct |
3,461
-67.43%
|
$418,781
$121.88 P/Share
|
|
Aug 15
2024
|
William H Rastetter Director |
SELL
Open market or private sale
|
Direct |
14,250
-27.54%
|
$2,080,500
$146.69 P/Share
|
|
Aug 13
2024
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
11,570
-8.86%
|
$1,735,500
$150.43 P/Share
|
|
Aug 13
2024
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,570
+8.14%
|
$485,940
$42.76 P/Share
|
|
Aug 13
2024
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
14,100
-30.9%
|
$2,115,000
$150.38 P/Share
|
|
Aug 13
2024
|
Matt Abernethy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,100
+23.61%
|
$1,029,300
$73.6 P/Share
|
|
Aug 13
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
7,143
-46.79%
|
$1,071,450
$150.11 P/Share
|
|
Aug 13
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,043
+23.97%
|
$313,429
$103.52 P/Share
|
|
Aug 06
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
273
-3.97%
|
$40,131
$147.7 P/Share
|
|
Aug 06
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
273
+3.82%
|
$21,567
$79.02 P/Share
|
|
Aug 01
2024
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
12,632
-40.97%
|
$1,932,696
$153.26 P/Share
|
|
Aug 01
2024
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,632
+29.06%
|
$770,552
$61.82 P/Share
|
|
Aug 01
2024
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,996
-7.01%
|
$461,384
$154.01 P/Share
|
|
Aug 01
2024
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,996
+6.55%
|
$236,684
$79.02 P/Share
|
|
Jul 16
2024
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
900
-4.71%
|
$135,000
$150.04 P/Share
|
|
Jul 16
2024
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+4.5%
|
$54,900
$61.82 P/Share
|
|
Jul 16
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
2,857
-11.41%
|
$428,550
$150.05 P/Share
|
|
Jul 16
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,957
+9.74%
|
$201,571
$103.52 P/Share
|
|
Jul 16
2024
|
Gary A Lyons Director |
SELL
Open market or private sale
|
Direct |
930
-0.78%
|
$139,500
$150.03 P/Share
|
|
Jul 16
2024
|
Gary A Lyons Director |
BUY
Exercise of conversion of derivative security
|
Direct |
930
+0.77%
|
$39,060
$42.76 P/Share
|
|
Jul 16
2024
|
Matt Abernethy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
900
-2.78%
|
$135,000
$150.04 P/Share
|
|
Jul 16
2024
|
Matt Abernethy Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+2.7%
|
$65,700
$73.6 P/Share
|
|
Jul 16
2024
|
Darin Lippoldt Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
7,004
-14.98%
|
$1,050,600
$150.0 P/Share
|
|
Jul 16
2024
|
Darin Lippoldt Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,004
+13.03%
|
$553,316
$79.02 P/Share
|
|
Jul 01
2024
|
Julie Cooke Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
10,000
-35.46%
|
$1,400,000
$140.19 P/Share
|
|
Jul 01
2024
|
Julie Cooke Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+26.18%
|
$610,000
$61.82 P/Share
|
|
Jul 01
2024
|
Ingrid Delaet Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct |
272
-3.5%
|
$37,536
$138.11 P/Share
|
|
Jul 01
2024
|
Ingrid Delaet Chief Regulatory Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
272
+3.38%
|
$21,488
$79.02 P/Share
|